Skip to content

Clinical trials

Carcinoma, Hepatocellular trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Country / region: Hong Kong Clear all

115 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20052
20064
20074
20084
20096
20106
20116
20123
20139
20145
20156
20163
20174
20189
20197
20208
20212
20228
20235
20245
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed71
Terminated16
Active, not recruiting11
Recruiting11
Unknown status5
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong18
The University of Hong Kong12
AstraZeneca10
Bayer8
Bristol-Myers Squibb8
Hoffmann-La Roche6
Novartis Pharmaceuticals6
Bio-Cancer Treatment International Limited4
Humanity & Health Medical Group Limited4
Pfizer4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular115
Liver Neoplasms31
Neoplasms12
Carcinoma6
Liver Diseases3
Adenocarcinoma2
Biliary Tract Neoplasms2
Digestive System Diseases2
Digestive System Neoplasms2
Hepatitis B2

Trials

Showing 26 to 50 of 115. Each trial links to its page on Pharma Observatory.

15 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.